Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-serine and Cognitive Remediation in Schizophrenia
NCT01474395Phase 2Unknown
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- Mar 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-serine in schizophrenia, schizoaffective disorder, sponsored by Nathan S. Kline Institute for Psychiatric Research. Status: unknown.
02
Drugs
d-serine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01474395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01474395.